Research programme: red blood cell growth factor - Interneuron

Drug Profile

Research programme: red blood cell growth factor - Interneuron

Alternative Names: Red blood cell growth factor research programme - Interneuron; Red blood cell growth factor research programme - ZymoGenetics; Research programme: red blood cell growth factor - ZymoGenetics

Latest Information Update: 13 Jul 1999

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Indevus Pharmaceuticals
  • Developer Indevus Pharmaceuticals; ZymoGenetics
  • Class
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Anaemia

Most Recent Events

  • 13 Jul 1999 Research programme: red blood cell growth factor - Progenitor is now called Research programme: red blood cell growth factor - Interneuron
  • 13 Jul 1999 Discontinued-Preclinical for Anaemia in USA (Unknown route)
  • 10 Feb 1998 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top